Private Equity

A new partnership between Per Aarsleff and LiquiForce brings advanced European tech to fix Canada's failing water pipes, promising a faster, no-dig future.

GameChange Energy acquires Terrasmart's eBOS unit, expanding its module-to-grid offerings and boosting U.S. solar manufacturing in a major industry shift.

Renewbrook Energy acquires PosiGen's distressed solar assets, promising stability for thousands of customers left in limbo after PosiGen's bankruptcy.

Epika Fleet Services expands its national network, partnering with Miami's Freeway Fleet to bolster its presence in the critical Southeast market.

With the launch of Steelforce America, the global steel firm appoints a new CEO to capture growth in a dynamic, multi-billion dollar market.

Mopec Group appoints Scott Nudelman to lead its new Certified Service division, a strategic move to boost lab uptime and gain a competitive edge.

A lucrative deal for a rare disease voucher positions Fortress Biotech for profitability, highlighting a successful strategy and a breakthrough for Menkes patients.

With its stock under pressure, Geron will face investors to defend its RYTELO sales strategy and address delays in its pivotal myelofibrosis trial.

After a three-year wait, Firehouse Subs unveils its protein-packed Chicken 'N' Cheddar Rancher, a strategic move blending premium ingredients with philanthropy.

BioVie faces a pivotal moment, touting breakthrough drugs for Alzheimer's and cirrhosis while navigating clinical setbacks and financial pressures.

As cardiovascular disease affects nearly half of US adults, experts are urging a shift to existing, life-saving therapies that are widely ignored.

A five-year pivot from office buildings to luxury apartments culminates in a blockbuster private buyout, validating a risky strategy and igniting the market.

Madison Capital Group offers a new DST for a luxury Asheville community, tapping a hot market facing a surge in supply and evolving economic crosscurrents.

With its newly approved VIZZ eye drop, LENZ Therapeutics is wooing investors, aiming to capture a slice of the massive, underserved presbyopia market.

With stellar trial data and a fast-tracked FDA submission, CG Oncology prepares for a pivotal presentation at the TD Cowen Health Care Conference.

A massive $500 million investment from top private equity firms will accelerate Vero Networks' mission to build high-speed fiber across the U.S.

A new high-grade discovery deep beneath a century-old mine could revive a legendary BC mining district and bolster Canada's critical mineral supply.

C4 Therapeutics begins a crucial study for its oral protein degrader, cemsidomide, offering new hope for heavily treated multiple myeloma patients.

Anavex Life Sciences adds AMEOS Group CEO Dr. Axel Paeger to its board, a strategic move signaling a push into European markets for its CNS therapies.

The biotech firm slashed a major acquisition hurdle in a deal with HealthCare Royalty, signaling strong confidence in its cancer drug ZYNLONTA's future.